Does maximizing programmed cell death necessarily yield an optimum clinical advantage?D. OU; K.M. Anderson; W. Leslie; P. Bonomi; J.E. Harris · 1999

Widespread countervailing genomic responses induced by chemotherapy or radiation as a cause of therapeutic failureK.M. Anderson; W.A. Alrefai; C.A. Anderson; P. Bonomi; J.E. Harris · 2000

Free radical spin traps as adjuncts for the prevention and treatment of diseaseK.M. Anderson; G. Ells; P. Bonomi; J.E. Harris · 1999

Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposalK.M. Anderson; P. Bonomi; J. Meng; J.E. Harris · 1998

A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell deathT. Buyn; P. Dudeja; J.E. Harris; D. Ou; T. Seed; D. Sawlani; J. Meng; P. Bonomi; K.M. Anderson · 1997

Increased cytosol Ca2+ and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886K.M. Anderson; W.A. Alrefai; P.K. Dudeja; S. Jadko; P. Bonomi; Y. Hu; D. Ou; J.E. Harris · 2002